Download PDF
Dtsch Med Wochenschr 2008; 133(41): 2084
DOI: 10.1055/s-0028-1091247
Pro & Contra | Commentary
Humangenetik, Onkologie
© Georg Thieme Verlag KG Stuttgart · New York

Genetische Testung in der Onkologie – pro

Genetic analysis in oncology – proO. Steinlein1
  • 1Institut für Humangenetik der Universität München
Further Information

Publication History

Publication Date:
01 October 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Gentest - erbliche Krebserkrankungen

Keywords

genetic testing - hereditary malignancies

Literatur

  • 1 Goetz M P, Kamal A, Ames M M. Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.  Clin Pharmacol Ther. 2008;  83 160-166
    Google Scholar
  • 2 Lefferts J A, Bartels C L, Tsongalis G J. Molecular oncology: current trends in diagnostics.  Future Oncol. 2008;  4 61-70
    Google Scholar
  • 3 Peppercorn J, Carey A L. Genotype-guided adjuvant endocrine therapy: new tricks from an old drug?.  Expert Rev Anticancer Ther. 2008;  8 191-194
    Google Scholar

Prof. Dr. Ortrud Steinlein

Institut für Humangenetik, Klinikum der Ludwig-Maximilians-Universität

Goethestr. 29

80336 München

Phone: 089/5160-4470

Fax: 089/5160-4468

Email: Ortrud.Steinlein@med.uni-muenchen.de